Non-small Cell Lung Cancer Therapeutics Industry - Strategy Analysis

 The global non-small cell lung cancer therapeutics market size was valued at USD 19.10 billion in 2023 and is projected to grow at a CAGR of 12.7% from 2024 to 2030. The market growth is attributed to the increasing rate of patients being diagnosed with lungs disorders. Increased consumption of tobacco products, deteriorating air quality due to air pollution, and unhealthy lifestyle have also contributed to the increase in lung cancer. Furthermore, increased investments by major medical institutes for research and development of medicines and treatments related to the non-small cell lung cancer (NSCLC) have resulted in the growth of this market.

Recent Development

•            In April 2022, AstraZeneca and Daiichi Sankyo received an additional biologics license to accept Enhertu (trastuzumab deruxtecan), which was approved by the US FDA for the treatment of adults with cancer other than cancer or those unable to cure it. (NWS).

•            In March 2019, Adorx Therapeutics signed a strategic agreement to collaborate with Johnson & Johnson Innovation to develop new cancer treatments.

•            In May 2021, Amgen received FDA approval for LUMACRAS. In the treatment of non-small cell tumours.

Comments

Post a Comment

Popular posts from this blog

๐๐จ๐ซ๐ญ๐ก ๐€๐ฆ๐ž๐ซ๐ข๐œ๐š ๐๐ž๐ฐ๐›๐จ๐ซ๐ง ๐’๐œ๐ซ๐ž๐ž๐ง๐ข๐ง๐  ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ข๐ณ๐ž, ๐’๐ก๐š๐ซ๐ž & ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ (๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ“)

Image
๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ƒ- https://lnkd.in/dgM4Yq8y The North America newborn screening market is witnessing robust growth, with revenue increasing from 980 Million USD in 2020 to 1,370 Million USD in 2025, ultimately projected to reach 2,230 Million USD by 2035. This growth trajectory is attributed to increased test volumes, expanding screening panels, and greater public health investments. The upward trend underscores the region's commitment to improving neonatal health outcomes through early and comprehensive diagnostic programs, further supported by rapid technological innovation. Key Drivers Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes. In 2024, PerkinElmer Inc. expanded its reagent kit offerings to meet regulatory inclusions for Cystic Fibrosis and Sickle Cell Disease screening. Key Trends Adoption of multiplex testing technologies is accelerating, allowi...
Read more

๐”๐’ ๐’๐ญ๐ซ๐ฎ๐œ๐ญ๐ฎ๐ซ๐š๐ฅ ๐€๐๐ก๐ž๐ฌ๐ข๐ฏ๐ž ๐“๐š๐ฉ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ“ - ๐’๐–๐Ž๐“ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ง๐ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐จ๐ฃ๐ž๐œ๐ญ๐ข๐จ๐ง๐ฌ

Image
  ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐‘๐ƒ- https://bussinessinsights.com/rd/chemical-&-material/us-structural-adhesive-tapes-market   The US structural adhesive tapes market is expected to demonstrate consistent growth, with total revenue rising from $1,900 million in 2020 to a projected $4,320 million by 2035. The surge in demand is attributable to rapid industrial advancements, emphasis on sustainability, and new applications across critical sectors. 2025 is estimated at $2,450 million, showing a clear upward trend, with further acceleration anticipated due to innovation in product offerings and expansion in end-user industries. Sustained R&D investment and adaptation to regulatory changes will underpin long-term growth.   Key Drivers Growth in the automotive and aerospace sectors, where structural adhesive tapes are replacing mechanical fasteners for improved assembly efficiency, reduced weight, and enhanced safety. For example, 3M has launched new lightweight bonding...
Read more

Electronic Expansion Valves (EEV) Industry - Strategy Analysis

  The global sales of electronic expansion valves are estimated to be worth USD 886.5 million in 2025 and are anticipated to reach a value of USD 1,986.0 million by 2035. Sales are projected to rise at a CAGR of 8.4% over the forecast period between 2025 and 2035. The revenue generated by electronic expansion valves in 2024 was USD 817.8 million. The industry is anticipated to exhibit a Y-o-Y growth of 8.8% in 2025. Electronic expansion valves (EEVs) are critical components in refrigeration and HVAC systems, as they control the amount of refrigerant flowing into the evaporator but in intelligent way considering the feedback provided during the operation. Unlike traditional valves, EEVs utilize electronic control mechanisms to optimize system performance, ensuring efficient heat transfer and maintaining desired conditions. The expansion valves’ capacity to self-adjust with dynamic loads also improves energy efficiency and curbs costs, which, aligning with modern energy-saving g...
Read more